Moscow Institute of Physics and Technology (MIPT) – Russian leading technical university, based in Dolgoprudny town, Moscow Region. MIPT has an outstanding history, having Nobel Prize winners Pyotr Kapitsa, Nikolai Semyonov and Lev Landau among its founders and researchers. Several alumni of the Institute have also been awarded Nobel Prizes and many of its professors are among top Russian scientists today (the Institute has more than 80 academicians and corresponding members of the Russian Academy of Sciences).
The ChemRar High-Tech Center is a unique non-government R&D complex and innovation business-incubator which brings together high-tech organizations that use ‘post-genomic’ technologies to develop new drugs in partnership with Russian and foreign pharmaceutical and biotechnological manufacturers.
PROTEK is one of the largest pharmaceutical holdings in Russia. The group has a diversified business structure and works in all main segments of the pharmaceutical industry: drug manufacture, distribution of pharmaceutical products, beauty and health products, as well as retail.
PHARMZASCHITA specialises in development and production of drugs and treatment methods to counter the effect of exposure to radiation. Its main activities are:
  • Development of drugs which protect against the effects of radiation.
  • Development of drugs to counter illness caused by exposure to radiation;
  • Production of 12 drugs and 8 medicines;
  • Production of personal anti-radiation kits.
    AKRIKHIN is one of the top 5 Russian pharmaceutical manufacturers by total sales and production. The company’s product portfolio contains more than 150 drugs for treatment of a broad range of illnesses. Akrikhin produces many essential and widely used drugs, as well as products for treatment of tuberculosis and diabetes.
    SKOLKOVO BIOMEDICAL CLUSTER – the largest science and technology complex in Russia which works on development and commercialisation of new technologies. The Cluster includes 215 innovation-based enterprises engaged in projects in the field of creating new drugs, medical diagnostic and therapeutic devices, new biocompatible materials, cell technology products and bioinformatics projects.
    Institute of medical and biological studies (IMBP) was founded in 1963 following an initiative from academicians M. Keldysh and S. Korolyov and charged with research, design and testing in order to provide medical and biological equipment and services for manned space ships, as well as fundamental research in the field of space biology and medicine. Since 1994 the Institute has been registered as a State scientific centre of the Russian Federation. Since 2001 – one of the research institutions of the Russian Academy of Sciences.
    R&D Institute of acute care n.a. sklifosovsky is the largest multifunctional centre of acute care in Russia engaged both in research and practical work. All its units provide free of charge round-the-clock high quality medical services to anyone who needs it. The institute is engaged in research activities, providing medical care, training and consulting professionals in the field of emergency medicine. The institute comprises over 40 scientific units, with over a half of them clinical. Owing to the staff’s expertise and potential, as well as the state of the art equipment the institute is able to successfully develop and improve existing diagnostic and treatment techniques of the most severe injuries and acute surgical conditions with complications. The institute employs over 800 researchers and doctors. Over 20,000 various surgeries are performed at the institute’s facilities each year.
    Federal research and treatment centre of pAediatric haematology, oncology and immunology n.a. Dmitry Rogachov is a unique state institution combining a research centre, a hospital and a training facility for several leading Russian universities. It brings together many years of doctors’ practical experience and innovations in the field of medicine, science and technology. The institution was founded in 1991 as a research and development institute of paediatric haematology. The Centre provides specialist high-tech medical services to children of all ages from all over Russia at its day-time, full-time and outpatient departments. The Centre works on development and implementation of unified internationally recognised treatment protocols for blood diseases, immunologic diseases, malign growths and other grave paediatric conditions.
    Altonika together with its medical subsidiary Altomedica is among Russian companies leading the industry of development and manufacturing of medical equipment. The business has been running for over 25 years and has all the necessary expertise to provide versatile diagnostic equipment: ECG machines, diagnostic complexes, bedside monitors and monitoring systems, spirometers and pulseoxymetry devices. Altonika covers the whole process of development and production in Russia. It designed and built a plant in Zelenograd for its own production purposes equipped with state of the art assembly lines to guarantee perfect quality at each stage. Latest technologies are used to develop the equipment and all the necessary requirements are met. We believe that consumers should receive user-friendly, practical and reliable end-products.
    The Geropharm corporate group is among the top 20 leading Russian pharmaceutic companies. It specialises in development and production of innovative drugs against socially significant diseases and in generics prioritised for import phase-out. It was included in the list of leading Russian high-tech companies ‘TechUspekh’ and rated within the top 30 businesses in 2012 and the top 10 – in 2013. GEROPHARM is the only business manufacturing original drugs Kortexin® and Retinalamin® produced in accordance with a patented technology. In 2013 the company launched a drug called Levetinol® used to treat epilepsy. GEROPHARM-Bio produces genetically engineered insulins, Rinsulin R® and Rinsulin NPH®, covering the whole process of production. The medicines come in a variety of forms and match the quality standards of British and American pharmacopeia.
    Quantum Phamaceuticals is a biotechnological company started in Moscow in 2002. Its main field of work is creating molecular modelling tools designed to search for new biologically active small molecules. The technology can be applied in various spheres, including discovery of new low molecular weight medication candidates, hit identification, predictions of the ADMET properties, discovery of the action mechanism of drug substances and development of a continuous vector space water model for molecular modelling of nano-systems in aqueous environment. The company runs some of the projects in cooperation with leading R&D centres.
    Federal research centre for transplantology and artificial organs n.a. v.i. shumakov under the russian ministry of health is a unique research and treatment centre which works on the whole complex of biological, technical, technological and medical issues related to transplantology and artificial organs. The Centre is constantly developing and applying latest high technologies of treatment and diagnostics, latest trends in transplantology, heart and vascular surgery, functional diagnostics, regeneration medicine, immunology, use of artificial organs and assisted circulation at the hospital.
    The litech research and production company was founded in 1992 as part of the R&D institute of Physical and Chemical Medicine under the Russian Academy of Medical Sciences. Today it is one of the most established and widely-recognised companies on the Russian market of laboratory diagnostics. LITECH was among the first companies in Russia to start using the polymerase chain reaction method in the Russian healthcare system for diagnosing infectious diseases. The company uses latest technologies in development of its products and actively introduces new effective techniques in laboratory diagnostics: mass spectroscopy, biochips, genotyping and antibiotics resistance detection.
    Janssen is a pharmaceutical subsidiary of the Johnson & Johnson international corporation. Since its creation in 1953 Janssen has been discovering and developing new high-quality medications. Over the course of its history it has developed over 180 drug substances. 80 of them provided the basis for innovative drugs and 8 of them are included by the World Health Organisation in the list of vital and essential drugs. Janssen is one of the leaders of the Russian pharmaceutic industry and is working on developing cures for serious medical issues in the fields of oncology (multiple myeloma and prostate cancer), immunology (psoriasis), psychiatry (schizophrenia, Alzheimer's disease), infectious diseases (HIV/AIDS, Hepatitis С and tuberculosis), as well as cardiovascular diseases and metabolic diseases (diabetes).
    The centre for biogerontology and regeneration medicine within MIPT is engaged in studying the issues of ageing and development of innovative technologies for prolongation of life. The Centre is charged with analysing anti-ageing technologies, overviewing promising research trends, building data bases for ageing biomarkers and geroprotectors, developing training programmes presenting age-related processes and potential countermeasures. The Centre will encourage international cooperation in the field through workshops and conferences.
    Moscow Region National research and treatment instite n.a. M.F. Vladimirsky (aka moniki) is a unique multifunctional centre with a 240-year-long history. It works in three fields: research (science and organisation), training and treatment. MONIKI is the leading research and development, clinical and educational centre in Moscow region. This complex includes over 48 research units and employs over 2,500 members of staff. Over 26,000 high-tech operations are performed at the institute each year and over 250,000 patients redirected here from virtually all health organisation of Moscow region are seen at the diagnostics department.
    Medstarnet rus llc is an international company specialising in medical IT-solutions. The company’s developments are aimed at providing ways to analyse big data in medicine, which would make treatments personalised. The company also strives to provide hospital personnel with information support, efficient expert systems and decision-making support systems. In other words, it aims to simplify the processes of cooperation and data exchange between healthcare segments.
    Martinex Group leads the industry of therapeutic cosmetic medicine and medical aesthetics on the Russian market and the CIS. Martinex brings to the market the latest top quality goods. It is a leading company which specialises in mesotherapy and also develops and produces biopharmaceuticals, state of the art substances for skin rejuvenation produced using a unique method of solid-phase modification of hyaluronic acid. Martinex has its own international research centre which works under the aegis of UNESCO and in cooperation with many research institutes both in Russia and abroad. The company participates in the programme on creating a cure for cancer estimated to finish in 2020 (neutron and photon capture therapy), Federal programme-2020 for development of the medical industry and the Federal Presidential programme for nuclear medicine.
    Rostkhim llc is an innovation-based company developing new ways to produce valuable chemical products and appropriate manufacturing processes. The main fields of their activities include development of high-yield synthesis and manufacturing processes for 13С-products with higher isotope enrichment levels (99 %); development of synthesis and manufacturing processes for producing oxygenated (carbonyl) compounds through methods of catalytic carbonylation using high-yield metal complex catalysts; development of technologies and creation of new CO-producing prototype units (CO as a raw material for chemical industry); design supervision at the launch of drug manufacture based on their own developments in order to produce drug substances.
    neurology research centre is the largest Russian institution specialised in neurology with over a 70-year-long history and equipped to the standards of leading world centres doing similar work. Its most significant developments and discoveries of the recent years include the first recombinant gene therapy in the world against amyotrophic lateral sclerosis (AdeVasc); developing a performance MRI and other methods of intravital assessment of the key brain activity parameters; developing molecular-genetic, biochemical and proteomic biomarkers for socially significant neurological disorders; identifying the key factors for an Ischemic stroke in young age. The centre is heavily involved in large-scale research aimed at creating new neurologic rehabilitation methods based on computer, aerospace and robot technologies, including brain-machine interface technologies, as well as developments in the field of targeted precision neuromodulation of functional reserves and brain compensation abilities.
    The First moscow state medical university n.a. Sechenov is a leading medical university of Russia teaching over 15 students from all over the world. The University comprises 7 schools and an Institute of Professional Education. The University conducts fundamental and applied research in medicine and biology, pre-clinical and clinical evaluation of results and their introduction to the training process. Research and development activities are conducted in 8 fields identified in accordance with prioritised innovation and socially-significant trends.
    Zao NEurocom is a Russian company specialising in development and manufacture of transport security systems which reduce risks related to the human element. The company has developed and now produces a hardware and software complex for assessing and improving drivers’ psychophysiological characteristics and the Remote Vigilance Control System which monitors the driver’s performance capabilities using their galvanic skin resistance parameters. Another of their major projects is a system of support to the driver known as Vigiton® which is designed to constantly monitor the driver’s physiological state in order to prevent a transition from an active state to a state of psychophysiological relaxation or drowsiness. A gadget called Sonya (Russian for “sleepyhead”) is a bracelet to put around one’s palm which reads brain impulses, stimulates and prolongs the deep sleep stage, allowing to get enough sleep in a shorter time.
    State Research Centre niopic has been a leading centre in the Russian chemical industry, technologies and fine organic synthesis products for over 80 years. Since 1994 NIOPIC has been registered as a state research centre of the Russian Federation. Its scientific units and pilot production are engaged in the entire cycle of development, starting with fundamental, applied and technological research all the way through to experimental development, design and development of mass production. An important field of its activities is developing a market for innovative products. The centre has developed and introduced to production and clinical practice such medications as Photosense® and Alasense® used for fluorescent diagnostics and photodynamic therapy against cancer and other serious illnesses. It has developed, tested and introduced to production, according to all the GMP requirements, technologies for 15 import phase-out drugs included in the Vital and Essential Drug List.
    XI Ventures is a Russian investment company specialising in investments in small innovation-based enterprises working in the field of life sciences at seed stage and in project investment. The company is a member of Biopharmaceutical Cluster ‘Northern’. It was founded following an initiative by Oleg Korzinov and Nikolai Savchuk, MIPT alumni and businessmen experienced in commercialising scientific research results in the field of life sciences.
    Constel LLC develops and manufactures medical and industrial equipment as well as software. Its main products include:
    Precision measuring insulation converters for industrial automation;
    Current control and protection devices;
    CARDIOPULSAR, an external counterpulsation device
    SKAD-2, a device registering blood pressure pulse wave oscillations;
    BARS-GD, a complex for breathing multi-component gas mixtures;
    Automation complexes for aero-space medicine.
    CONMET produces medical instruments and implants from titanium using unique techniques of image processing and methods of spatial design. Using CONMET technologies implant constructions can be fitted to measure before the operation, which reduces the time of the operation and increases its accuracy. CONMET implant prototypes are made using a 3D-printer, all the products are certified and authorised after a whole set of tests.
    Medical technologies ltd is a leading Russian developer and manufacturer of innovative high-tech digital X-ray medical equipment. The company works in the following fields: breast care; radiology; MRI; ultrasonic testing;
    paediatric X-ray diagnostics; IT in medicine; complexes for fitting out radiology departments.
    DONA-M is an innovation-based company specialising in development and production of high-tech medical devices and equipment for injury treatment, orthopaedics and cardiology. DONA-M developed a Set of prosthetic implants and tools for their installation as replacement for injured ligaments and tendons. The company is currently developing a system for endoprosthesis replacement of an entire knee in cooperation with experts from the department of traumatology and orthopaedics of Peoples' Friendship University of Russia and the Central Institute of Traumatology and Orthopaedics. The system will be based on latest technologies and cutting edge abrasion resistant finishes. This bionic system is patented in the Russian Federation. Since 2006 within the experiments conducted by the Federal Research Centre of Traumatology and Orthopaedics n.a. Shumakov the company has been involved in development of implant systems for assisted circulation and blood pumping systems, including organ perfusion equipment. The works resulted in an assisted circulation device AVK-N produced in cooperation with OAO ZITS and OOO BIOSOFT-M. DONA-M produces the assisted circulation device itself as well as required implantable components.
    M.A. Ster is a centre for gas sterilisation in the city of Lukhovitsy in Moscow region. The company was founded in 2002 has been providing medical instrument sterilisation services using a gas mixture of ethylene oxide and carbon dioxide since 2008. The business has five chambers for medical instrument sterilisation with a capacity of an 80 m3 single load of products each. The annual project capacity is 60,000 europallets. The company has a GOST ISO 13485ООО M.A. Ster certificate, a certificate from the German MDC Gmbh for its quality management system EN ISO 13485 (production of medical devices) and EN ISO 11135 (Validation). M.A. Ster is located on an area of 2.5 hectares with a total area of production space of 4,100 m2. The sterilisation centre works 24/7.